Literature DB >> 8337171

Risk taking and decision making of adolescent long-term survivors of cancer.

P J Hollen1, W L Hobbie.   

Abstract

Late effects of multi-modal treatments for long-term survivors of childhood cancer may affect their ability to make decisions related to risk behaviors. Adolescent survivors may be at greater risk than those in the general population because of late effects of organ compromise and oncogenesis. The purposes of this study were to (1) describe the prevalence of risk behaviors among adolescent long-term survivors of cancer; (2) describe these survivors' perceptions of the quality of their decision making; (3) test the hypothesis that the poorer the decision-making quality, the more risk behaviors exhibited by an adolescent long-term survivor; and (4) examine the effects of central nervous system (CNS) prophylactic leukemia therapy and academic achievement problems on quality of decision making and risk behaviors. In this descriptive study, a semi-structured interview was used at the time of the yearly clinic visit. The sample consisted of 36 long-term survivors who were disease-free for five years, had no medical treatment for two years, and were 14-19 years of age. The major conclusions drawn regarding adolescent long-term survivors were that (1) although there was a trend toward higher experimental use of some risk behaviors, essentially, the prevalence rates were comparable to those of the general population; (2) some were good decision makers; however, quality decision-making skills were poorly practiced by the majority; (3) with better decision-making quality, fewer risk behaviors were exhibited; and (4) prior CNS prophylactic leukemia therapy and academic achievement problems may be associated with poor quality decision making.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8337171

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  7 in total

1.  Adolescent cancer survivors' smoking intentions are associated with aggression, attention, and smoking history.

Authors:  Lisa S Kahalley; Vida L Tyc; Stephanie J Wilson; Jenna Nelms; Melissa M Hudson; Shengjie Wu; Xiaoping Xiong; Pamela S Hinds
Journal:  J Cancer Surviv       Date:  2010-10-05       Impact factor: 4.442

2.  Risk factors for smoking among adolescent survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Lisa S Kahalley; Leslie A Robinson; Vida L Tyc; Melissa M Hudson; Wendy Leisenring; Kayla Stratton; Ann C Mertens; Lonnie Zeltzer; Leslie L Robison; Pamela S Hinds
Journal:  Pediatr Blood Cancer       Date:  2011-05-25       Impact factor: 3.167

3.  Anti-Smoking Communication to Preadolescents with and without a Cancer Diagnosis: Parents and Healthcare Providers as Important Communicators.

Authors:  Leslee Throckmorton-Belzer; Vida L Tyc; Leslie A Robinson; James L Klosky; Shelly Lensing; Andrea K Booth
Journal:  Child Health Care       Date:  2009-10-01

4.  Attentional and executive dysfunction as predictors of smoking within the Childhood Cancer Survivor Study cohort.

Authors:  Lisa S Kahalley; Leslie A Robinson; Vida L Tyc; Melissa M Hudson; Wendy Leisenring; Kayla Stratton; Lonnie Zeltzer; Ann C Mertens; Leslie L Robison; Pamela S Hinds
Journal:  Nicotine Tob Res       Date:  2010-02-12       Impact factor: 5.825

5.  Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers.

Authors:  E Anne Lown; Robert Goldsby; Ann C Mertens; Thomas Greenfield; Jason Bond; John Whitton; Rachael Korcha; Leslie L Robison; Lonnie K Zeltzer
Journal:  Addiction       Date:  2008-07       Impact factor: 6.526

6.  Lifestyle behaviours of young adult survivors of childhood cancer.

Authors:  I Larcombe; M Mott; L Hunt
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

Review 7.  Health Behaviors of Childhood Cancer Survivors.

Authors:  Jennifer S Ford; Marie Barnett; Rachel Werk
Journal:  Children (Basel)       Date:  2014-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.